ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

INDP Indaptus Therapeutics Inc

2.11
-0.07 (-3.21%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Indaptus Therapeutics Inc INDP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.07 -3.21% 2.11 07:09:00
Open Price Low Price High Price Close Price Previous Close
2.22 2.0486 2.22 2.11 2.18
more quote information »

Recent News

Date Time Source Heading
11/4/202421:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
28/3/202423:00GLOBEIndaptus Therapeutics to Present at the MedInvest Biotech..
25/3/202423:30GLOBEIndaptus Therapeutics Previews Positive Mechanism of Action..
18/3/202423:00GLOBEIndaptus Therapeutics to Participate in Tribe Public Webinar..
13/3/202422:30GLOBEIndaptus Therapeutics Reports Fourth Quarter and Year-End..
05/3/202403:01EDGAR2Form 8-K - Current report
04/3/202423:30GLOBEIndaptus Therapeutics Announces Positive Results from Second..
16/2/202400:00GLOBEIndaptus Therapeutics to Present at the 2024 BIO CEO &..
09/2/202400:00GLOBEIndaptus Therapeutics Expands Digital Presence with Launch..
24/1/202408:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202408:05EDGAR2Form 8-K - Current report
05/1/202400:00GLOBEEuropean Patent Office Approves Key Patent for Indaptus..
07/11/202308:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:05EDGAR2Form 8-K - Current report
07/11/202308:01GLOBEIndaptus Therapeutics Reports Third Quarter 2023 Financial..
07/11/202300:13EDGAR2Form 8-K - Current report
07/11/202300:00GLOBEIndaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune..
01/11/202300:12EDGAR2Form 8-K - Current report
01/11/202300:01GLOBEIndaptus Therapeutics to Present Positive Pharmacodynamic..
27/9/202322:00GLOBEIndaptus Therapeutics to Present at the LD Micro Main Event..
26/9/202322:00GLOBERegistration Is Now Open For Tribe Public’s Webinar Event..
19/9/202322:00GLOBEIndaptus Therapeutics Doses First Patient in Second Cohort..
06/9/202322:05GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 25th..
17/8/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:10EDGAR2Form 8-K - Current report
14/8/202322:00GLOBEIndaptus Therapeutics Reports Second Quarter 2023 Financial..
10/8/202322:45EDGAR2Form 8-K - Current report
10/8/202322:45GLOBEIndaptus Therapeutics Announces Opening of Next Cohort in..
07/8/202322:00GLOBEIndaptus Therapeutics Appoints Industry Veteran Roger..
15/6/202322:00GLOBEIndaptus Therapeutics to Participate in the Maxim Group..
31/5/202322:30GLOBEIndaptus Therapeutics to Present at the Jefferies Healthcare..
11/5/202321:00GLOBEIndaptus Therapeutics Reports First Quarter 2023 Financial..
09/5/202322:00GLOBEFollowing Granting of Indian Patent, Indaptus Therapeutics..
01/5/202322:00GLOBEIndaptus Therapeutics’ Chief Scientific Officer Michael..

Your Recent History

Delayed Upgrade Clock